Evidence map›Paper›PMID 24219130›Full record

ArticleThyroid : official journal of the American Thyroid Association2014

A novel FOXE1 mutation (R73S) in Bamforth-Lazarus syndrome causing increased thyroidal gene expression.

Aurore Carré, Rasha T Hamza, Dulanjalee Kariyawasam, Loïc Guillot, Raphaël Teissier, Elodie Tron, Mireille Castanet, Corinne Dupuy, Mohamed El Kholy, Michel Polak

Abstract readCase Reports
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Identification of GermlineInternational journal of molecular sciences · 2024
    Article
  6. Disruption of theFrontiers in cell and developmental biology · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. New insights into thyroid hormone action.Pharmacology & therapeutics · 2017
    Review
  13. Mutations in BOREALIN cause thyroid dysgenesis.Human molecular genetics · 2017
    Article
  14. Case reports in genetics · 2017
    Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Aurore Carré1 Research Center for Growth and Signaling (INSERM U845), Université Paris Descartes , Sorbonne Paris Cité, Paris, France .
Rasha T Hamza
Dulanjalee Kariyawasam
Loïc Guillot
Raphaël Teissier
Elodie Tron
Mireille Castanet
Corinne Dupuy
Mohamed El Kholy
Michel Polak
Délégation Paris 5 · FRAin Shams University · EGUniversité Paris-Sud · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHomozygous loss-of-function mutations in the FOXE1 gene have been reported in several patients with partial or complete Bamforth-Lazarus syndrome: congenital hypothyroidism (CH) with thyroid dysgenesis (usually athyreosis), cleft palate, spiky hair, with or without choanal atresia, and bifid epiglottis. Here, our objective was to evaluate potential functional consequences of a FOXE1 mutation in a patient with a similar clinical phenotype.

methodsFOXE1 was sequenced in eight patients with thyroid dysgenesis and cleft palate. Transient transfection was performed in HEK293 cells using the thyroglobulin (TG) and thyroid peroxidase (TPO) promoters in luciferase reporter plasmids to assess the functional impact of the FOXE1 mutations. Primary human thyrocytes transfected with wild type and mutant FOXE1 served to assess the impact of the mutation on endogenous TG and TPO expression.

resultsWe identified and characterized the function of a new homozygous FOXE1 missense mutation (p.R73S) in a boy with a typical phenotype (athyreosis, cleft palate, and partial choanal atresia). This new mutation located within the forkhead domain was inherited from the heterozygous healthy consanguineous parents. In vitro functional studies in HEK293 cells showed that this mutant gene enhanced the activity of the TG and TPO gene promoters (1.5-fold and 1.7-fold respectively vs. wild type FOXE1; p<0.05), unlike the five mutations previously reported in Bamforth-Lazarus syndrome. The gain-of-function effect of the FOXE1-p.R73S mutant gene was confirmed by an increase in endogenous TG production in primary human thyrocytes.

conclusionWe identified a new homozygous FOXE1 mutation responsible for enhanced expression of the TG and TPO genes in a boy whose phenotype is similar to that reported previously in patients with loss-of-function FOXE1 mutations. This finding further delineates the role for FOXE1 in both thyroid and palate development, and shows that enhanced gene activity should be considered among the mechanisms underlying Bamforth-Lazarus syndrome.

Indexed as

Mutation, MissenseAbnormalities, MultipleAmino Acid SequenceAmino Acid SubstitutionAutoantigensBase SequenceCleft PalateDNA Mutational AnalysisForkhead Transcription FactorsGene ExpressionHair DiseasesHEK293 CellsHomozygoteHumansHypothyroidismInfantAutoantigensForkhead Transcription FactorsFOXE1 protein, humanIodide PeroxidaseIron-Binding ProteinsThyroglobulinTPO protein, human

Identifiers

PMID24219130
PMCPMC3993030
OpenAlexW1994877344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.